These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2432177)

  • 1. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.
    Palmer AM; Francis PT; Benton JS; Sims NR; Mann DM; Neary D; Snowden JS; Bowen DM
    J Neurochem; 1987 Jan; 48(1):8-15. PubMed ID: 2432177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain.
    Middlemiss DN; Palmer AM; Edel N; Bowen DM
    J Neurochem; 1986 Mar; 46(3):993-6. PubMed ID: 2419502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
    Bowen DM; Allen SJ; Benton JS; Goodhardt MJ; Haan EA; Palmer AM; Sims NR; Smith CC; Spillane JA; Esiri MM; Neary D; Snowdon JS; Wilcock GK; Davison AN
    J Neurochem; 1983 Jul; 41(1):266-72. PubMed ID: 6306169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
    Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
    Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication.
    Chen CP; Alder JT; Bowen DM; Esiri MM; McDonald B; Hope T; Jobst KA; Francis PT
    J Neurochem; 1996 Apr; 66(4):1592-8. PubMed ID: 8627315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy.
    Mann DM; Marcyniuk B; Yates PO; Neary D; Snowden JS
    Neuropathol Appl Neurobiol; 1988; 14(3):177-95. PubMed ID: 3405392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.
    Bowen DM; Procter AW; Mann DM; Snowden JS; Esiri MM; Neary D; Francis PT
    Psychopharmacology (Berl); 2008 Mar; 196(4):603-10. PubMed ID: 18026720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologic and neurochemical correlates of psychosis in primary dementia.
    Zubenko GS; Moossy J; Martinez AJ; Rao G; Claassen D; Rosen J; Kopp U
    Arch Neurol; 1991 Jun; 48(6):619-24. PubMed ID: 1710105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The temporal lobe in dementia of Alzheimer's type.
    Wilcock GK
    Gerontology; 1983; 29(5):320-4. PubMed ID: 6618185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.
    Palmer AM; Francis PT; Bowen DM; Benton JS; Neary D; Mann DM; Snowden JS
    Brain Res; 1987 Jun; 414(2):365-75. PubMed ID: 3620938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic cholinergic dysfunction in patients with dementia.
    Sims NR; Bowen DM; Allen SJ; Smith CC; Neary D; Thomas DJ; Davison AN
    J Neurochem; 1983 Feb; 40(2):503-9. PubMed ID: 6822833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
    Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical features of frontotemporal dementia.
    Procter AW; Qurne M; Francis PT
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():80-4. PubMed ID: 10436347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin (5-HT) in brains of adult patients with Down syndrome.
    Seidl R; Kaehler ST; Prast H; Singewald N; Cairns N; Gratzer M; Lubec G
    J Neural Transm Suppl; 1999; 57():221-32. PubMed ID: 10666678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated ageing or selective neuronal loss as an important cause of dementia?
    Bowen DM; White P; Spillane JA; Goodhardt MJ; Curzon G; Iwangoff P; Meier-Ruge W; Davison AN
    Lancet; 1979 Jan; 1(8106):11-4. PubMed ID: 83462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study.
    Meguro K; Yamaguchi S; Itoh M; Fujiwara T; Yamadori A
    Neurology; 1997 Oct; 49(4):941-5. PubMed ID: 9339671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.
    Mountjoy CQ; Rossor MN; Iversen LL; Roth M
    Brain; 1984 Jun; 107 ( Pt 2)():507-18. PubMed ID: 6722514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.